ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Sao Martinho Sa

Sao Martinho Sa (SMTO3)

25.45
0.62
(2.50%)
Cerrado 17 Diciembre 2:55PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
25.23
Postura de Compra
24.66
Postura de Venta
26.00
Volume Operado de la Acción
1,132,700
24.75 Rango del Día 25.59
23.75 Rango de 52 semanas 34.45
Capitalización de Mercado [m]
Precio Anterior
24.83
Precio de Apertura
24.96
Última hora de negociación
Volumen financiero
R$ 28,634,656
Precio Promedio Ponderado
25.28
Volumen promedio (3 m)
1,274,571
Acciones en circulación
346,375,066
Rendimiento del Dividendo
5.32%
Ratio Precio/Utilidad
5.92
Beneficio por acción (BPA)
4.26
turnover
7.18B
Beneficio neto
1.48B

Acerca de Sao Martinho Sa

Sector
Grain And Field Beans-whsl
Industria
Sugarcane And Sugar Beets
Sede
Pradopolis, Sao Paulo, Bra
Fundado
1943
Sao Martinho Sa is listed in the Grain And Field Beans-whsl sector of the Brazil Bovespa Exchange with ticker SMTO3. The last closing price for SÃO MARTINHO ON was R$24.83. Over the last year, SÃO MARTINHO ON shares have traded in a share price range of R$ 23.75 to R$ 34.45.

SÃO MARTINHO ON currently has 346,375,066 shares in issue. The market capitalisation of SÃO MARTINHO ON is R$8.60 billion. SÃO MARTINHO ON has a price to earnings ratio (PE ratio) of 5.92.

SMTO3 Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.37-1.445312525.626.8624.31138434025.35014245CS
40.411.6518936341724.8226.8624.29123057425.24772212CS
12-1.74-6.4516129032326.9728.3923.75127457125.85984291CS
26-5.35-17.495094833230.5834.4523.75147018328.27908294CS
52-3.43-11.967899511528.6634.4523.75170800128.23955549CS
156-10.46-29.30792939235.6952.921.38182188431.73547198CS
2603.0613.80243572422.1752.911.36165307430.17542615CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ATED3Atom Educacao E Editora S.A.
R$ 2.05
(39.46%)
267.1k
AGXY3Agrogalaxy Participacoes SA
R$ 0.50
(25.00%)
4.74M
DOTZ3Dotz S.A.
R$ 3.20
(18.96%)
68.4k
DASA11Diagnosticos da America S.A
R$ 1.08
(13.68%)
100
IFCM3Infracommerce Caxaas S.A.
R$ 0.09
(12.50%)
9.38M
COCE11Cia Energetica Ceara Coelce
R$ 0.39
(-35.00%)
11.7k
CRPG3TronoxPigmentos do Brasil S.A.
R$ 21.15
(-20.19%)
1.5k
QUAL3Qualicorp Consultoria e Corretora de Seguros S.A.
R$ 1.79
(-17.51%)
11.66M
EPAR3Embpar Participacoes S.A.
R$ 5.65
(-15.67%)
44.5k
AZEV3Azevedo Travassos Sa
R$ 1.07
(-13.71%)
1.29M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.28
(-11.28%)
313.56M
COGN3CognaEducacao SA
R$ 1.09
(1.87%)
80.64M
BBDC4Bco Bradesco Sa
R$ 11.99
(0.756303%)
66.96M
ITSA4Itausa Investimentos Itau SA
R$ 9.04
(0.110742%)
52.07M
ITUB4Itau Unibanco Holding SA
R$ 31.88
(0.536108%)
40.11M
JMoneyHoops JMoneyHoops 49 segundos hace
Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ
EATR
dstock07734 dstock07734 53 segundos hace
Yes
NWBO
KILLAZILLA KILLAZILLA 2 minutos hace
DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......
TLRY
gitreal gitreal 2 minutos hace
...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i
NBRI
flipper44 flipper44 3 minutos hace
Those people know we can still see them, right?
NWBO
awesomed007 awesomed007 3 minutos hace
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
awesomed007 awesomed007 3 minutos hace
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
Eatatjoes Eatatjoes 3 minutos hace
Paul Malec of Deer Park, NY
QOIL
fuagf fuagf 3 minutos hace
Yeps, yeps and yeps. Good ones.
NoMoDo NoMoDo 3 minutos hace
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.
HMBL
manibiotech manibiotech 3 minutos hace
Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you 
NWBO
1vman 1vman 4 minutos hace
*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔
UBQU
janice shell janice shell 5 minutos hace
First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so
HappyAlways HappyAlways 5 minutos hace
I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t
FNMA
TheDane TheDane 6 minutos hace
Not only did it hold but it’s on the way back up.
SMCI
OnTrack444 OnTrack444 6 minutos hace
Might see a dime after the RS!  

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!!  Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!!  GLTY
HMBL
manibiotech manibiotech 7 minutos hace
Interesting for sure but not conclusive which he repeat every day 

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience 


NWBO
FACT-MASTER FACT-MASTER 8 minutos hace
Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i
CDMO
arizona1 arizona1 8 minutos hace
Never trumpers are hilarious and brilliant too.
jimr1717 jimr1717 10 minutos hace
“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is
SINT
NoMoDo NoMoDo 11 minutos hace
If we don't see a dime, I will be shocked.
HMBL
Slyhunter Slyhunter 11 minutos hace
I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is
TSLA
nfrequent nfrequent 11 minutos hace
Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/
RNVA
XMaster2023 XMaster2023 11 minutos hace
Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will
NWBO